Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan for Atheroma Vulnerability in Deferred Coronary Disease
NCT01384747Phase 4Terminated
- Start
- Jul 2011
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fimasartan in coronary artery disease (CAD). Started Jul 2011; status: terminated.
02
Drugs
fimasartan
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01384747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384747.